
Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …

One of the strange paradoxes of our industry is that we have a very large number of new medicines in …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

